GenesisM, a joint venture of Bain Capital Real Estate and Botanic Properties, has broken ground on a 154,000-square-foot, Class A biomanufacturing facility in Bedford, Massachusetts, extending Boston’s prominence as a biopharma hub. Designed with enhanced core infrastructure for long-term operational flexibility, the facility supports multiple independent tenants with high power capacity and versatile layouts. Delivery of core shell is anticipated in Q3 2026, with tenant fit-outs starting as early as Q2 2026. This project addresses a critical gap in Boston-area life sciences manufacturing and aims to accelerate biopharma production capabilities in the region.